Article Text

Download PDFPDF

#337 Prognostic significance of lymph node ratio in patients with vulvar cancer
  1. Houyem Mansouri1,2,
  2. Ines Zemni3,2,
  3. Nedia Boujelbene4,2,
  4. Maher Slimene3,2,
  5. Riadh Chargui3,2 and
  6. Tarek Ben Dhiab3,2
  1. 1Regional Hospital of Jendouba, Department of surgical Oncology, Jendouba, Tunisia
  2. 2Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia
  3. 3Salah Azaiz Institute,Department of Surgical Oncology, Tunis, Tunisia
  4. 4Salah Azaiez Institute, Department of Pathology, Tunis, Tunisia


Introduction/Background The aim of this study was to investigate the prognostic value of lymph node ratio (LNR) in patients with vulvar cancer (VC).

Methodology We retrospectively included 192 patients treated for VC at the Salah Azaiez Institute between 1994 and 2022. LNR was stratified into 2 groups: LNR <0.2 and LNR ≥0.2. We analyzed survival rates and studied the correlation between LNR and clinical and pathological factors.

Results The mean age was 64.93± 13.817 years (range, 24–104 years). Surgery consisted of a radical vulvectomy, hemivulvectoy, and pelvic exenteration in respectively 96.4%, 2.1%, and 1.6% of cases. Lymph node (LN) dissection was bilateral in 88.5% of cases and the mean number of retrieved lymph LN was 14. The mean tumor size was 42.21± 24.018 mm. LN metastasis was assessed in 67 patients (34.9%). Tumors were classified as stage FIGO I, II, III, and IV in 55.2%, 9.4%, 32.8%, and 2.6% of cases respectively. LNR<0.2 and ≥0.2 were recorded in respectively 86.9% and 13.2% of cases. On univariate analysis, LNR>0.2 was correlated to tumor grade (30% in grades 2 and 3 vs 11.3% in grade 1, p=0.021), the tumor size (19.4% in tumor>40mm vs 9.3% in the others, p=0.045), the presence of lymphovascular space invasion (66.7% vs 15.7%,p=0.021) and perineural invasion (46.7% vs 12.5%,p=0.001). With a mean follow-up time of 35.48±35.48 months, the 5-year overall survival (OS) in patients with LNR<0.2 and LNR≥0.2 was 58.5% and 11.6% respectively (p<0.0001) and the 5-year free survival (RFS) was 60.3% and 20.5%, respectively (p<0.0001). On multivariate analysis, LNR was an independent prognostic factor of OS (HR=5.702, 95% confidence interval CI= 2.282–14.245, p<0.0001) and RFS (HR=2.911, 95% CI= 1.468–5.779, p=0.002).

Conclusion LNR is associated with an aggressive tumor and represents an independent prognostic factor of both OS and RFS

Disclosures NO CONFLICT of interest

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.